| scholarly article | Q13442814 |
| P50 | author | Izelle Labuschagne | Q56936053 |
| Marina Papoutsi | Q59036432 | ||
| Sarah J. Tabrizi | Q24039464 | ||
| Julie C. Stout | Q45290281 | ||
| P2860 | cites work | Outcomes of a computer-based cognitive rehabilitation program on Alzheimer's disease patients compared with those on patients affected by mild cognitive impairment. | Q50772194 |
| Participation in cognitively stimulating activities and risk of incident Alzheimer disease. | Q52014336 | ||
| Real-Time Functional Magnetic Resonance Imaging Neurofeedback for Treatment of Parkinson's Disease | Q57743474 | ||
| Task-Set Switching Deficits in Early-Stage Huntington's Disease: Implications for Basal Ganglia Function | Q57913121 | ||
| Long-term effects of cognitive training on everyday functional outcomes in older adults | Q24602305 | ||
| Memory enhancement in healthy older adults using a brain plasticity-based training program: a randomized, controlled study. | Q24684349 | ||
| Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders? | Q26824270 | ||
| Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing | Q30496995 | ||
| Cognitive reserve and brain reserve in prodromal Huntington's disease | Q30541757 | ||
| Video game training enhances cognitive control in older adults | Q30575914 | ||
| Concurrent activation of striatal direct and indirect pathways during action initiation. | Q30579307 | ||
| Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data | Q30624346 | ||
| Functional and connectivity changes during working memory in Huntington's disease: 18 month longitudinal data from the IMAGE-HD study. | Q30661116 | ||
| Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study. | Q30670030 | ||
| Functional changes during working memory in Huntington's disease: 30-month longitudinal data from the IMAGE-HD study. | Q30696281 | ||
| Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease | Q31105242 | ||
| Applications of real-time fMRI. | Q31172605 | ||
| The role of the basal ganglia in learning and memory: neuropsychological studies | Q33390025 | ||
| Functional imaging in Huntington's disease | Q33403110 | ||
| Cognitive reserve | Q33452282 | ||
| Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data | Q33489152 | ||
| Differential loss of striatal projection neurons in Huntington disease | Q33637273 | ||
| Huntington's disease: from molecular pathogenesis to clinical treatment | Q33773061 | ||
| Real-time fMRI: a tool for local brain regulation | Q33926401 | ||
| Exercise: a behavioral intervention to enhance brain health and plasticity | Q33959877 | ||
| Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism. | Q33976362 | ||
| An active and socially integrated lifestyle in late life might protect against dementia | Q33978519 | ||
| Real-time fMRI and its application to neurofeedback | Q34054595 | ||
| Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data | Q34089875 | ||
| What is the impact of education on Huntington's disease? | Q34172955 | ||
| Cerebral cortex structure in prodromal Huntington disease | Q34204077 | ||
| The organization of the human striatum estimated by intrinsic functional connectivity | Q34290294 | ||
| Tapping linked to function and structure in premanifest and symptomatic Huntington disease | Q34455567 | ||
| Neurocognitive signs in prodromal Huntington disease | Q34474382 | ||
| Technology insight: noninvasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS. | Q34646129 | ||
| Thalamic metabolism and symptom onset in preclinical Huntington's disease | Q34692568 | ||
| Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease | Q35072636 | ||
| A tale of two factors: what determines the rate of progression in Huntington's disease? A longitudinal MRI study | Q35162891 | ||
| Striatal volume contributes to the prediction of onset of Huntington disease in incident cases | Q35612769 | ||
| An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus | Q35720477 | ||
| Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease. | Q35888638 | ||
| Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease. | Q36011977 | ||
| Cognitive training in Alzheimer's disease: a meta-analysis of the literature | Q36534246 | ||
| Measuring executive dysfunction longitudinally and in relation to genetic burden, brain volumetrics, and depression in prodromal Huntington disease | Q36603018 | ||
| Cognitive impairment in Huntington disease: diagnosis and treatment | Q36773397 | ||
| Preclinical Huntington's disease: compensatory brain responses during learning | Q36846810 | ||
| Detection of Huntington's disease decades before diagnosis: the Predict-HD study | Q36941187 | ||
| Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset | Q37073913 | ||
| Brain reserve and the prevention of dementia | Q37125840 | ||
| An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease | Q45306122 | ||
| Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI. | Q45306386 | ||
| Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis | Q45307235 | ||
| Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease | Q45307289 | ||
| Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice. | Q45307374 | ||
| Evidence for segregated and integrative connectivity patterns in the human Basal Ganglia | Q45716308 | ||
| Lifetime antecedents of cognitive reserve | Q47819027 | ||
| Huntington disease | Q48465200 | ||
| Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity | Q37132239 | ||
| Functional compensation of motor function in pre-symptomatic Huntington's disease | Q37201396 | ||
| Cognitive decline in prodromal Huntington Disease: implications for clinical trials | Q37227655 | ||
| Cognitive domains that predict time to diagnosis in prodromal Huntington disease | Q37267442 | ||
| The cognitive functions of the caudate nucleus | Q37281865 | ||
| Can cognitive exercise prevent the onset of dementia? Systematic review of randomized clinical trials with longitudinal follow-up | Q37395637 | ||
| Interregional compensatory mechanisms of motor functioning in progressing preclinical neurodegeneration | Q37505020 | ||
| The neurobiology of brain and cognitive reserve: mental and physical activity as modulators of brain disorders | Q37612436 | ||
| Dopamine and glutamate in Huntington's disease: A balancing act. | Q37734563 | ||
| Mechanisms mediating brain and cognitive reserve: experience-dependent neuroprotection and functional compensation in animal models of neurodegenerative diseases. | Q37812899 | ||
| Cognitive functions and corticostriatal circuits: insights from Huntington's disease. | Q37827939 | ||
| Emotion recognition in Huntington's disease: a systematic review | Q37893737 | ||
| Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function. | Q37930190 | ||
| A review of cognition in Huntington's disease | Q38070573 | ||
| The basal ganglia and rule-governed language use: evidence from vascular and degenerative conditions. | Q38417649 | ||
| Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis | Q39809906 | ||
| In vivo evidence for the selective subcortical degeneration in Huntington's disease. | Q39991119 | ||
| Pallidal neuronal discharge in Huntington's disease: support for selective loss of striatal cells originating the indirect pathway | Q41563648 | ||
| Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia | Q44045758 | ||
| Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice | Q44842418 | ||
| Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness | Q45289548 | ||
| Emotion recognition in Huntington's disease and frontotemporal dementia | Q45289760 | ||
| Emotional face recognition deficits and medication effects in pre-manifest through stage-II Huntington's disease | Q45290217 | ||
| Prefrontal activity in Huntington's disease reflects cognitive and neuropsychiatric disturbances: the IMAGE-HD study. | Q45290568 | ||
| Altered frontostriatal coupling in pre-manifest Huntington's disease: effects of increasing cognitive load. | Q45290709 | ||
| Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease | Q45291252 | ||
| Sensorimotor mapping affects movement correction deficits in early Huntington's disease | Q45296775 | ||
| A retrospective study of the impact of lifestyle on age at onset of Huntington disease. | Q45298844 | ||
| Delaying the onset of Huntington's in mice | Q45300228 | ||
| Visuomotor integration deficits precede clinical onset in Huntington's disease | Q45300601 | ||
| Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice. | Q45301264 | ||
| Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease | Q45301408 | ||
| "Brain training" improves cognitive performance and survival in a transgenic mouse model of Huntington's disease | Q45301758 | ||
| Connectivity-based segmentation of the striatum in Huntington's disease: vulnerability of motor pathways | Q45301952 | ||
| The impairment of emotion recognition in Huntington's disease extends to positive emotions | Q45302113 | ||
| Clinical markers of early disease in persons near onset of Huntington's disease. | Q45303704 | ||
| Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches | Q45304893 | ||
| Environmental enrichment slows disease progression in R6/2 Huntington's disease mice | Q45305273 | ||
| Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease | Q45305470 | ||
| fMRI detection of early neural dysfunction in preclinical Huntington's disease | Q45305904 | ||
| Psychomotor, executive, and memory function in preclinical Huntington's disease | Q45305988 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phenotype | Q104053 |
| Huntington's disease | Q190564 | ||
| pathology | Q7208 | ||
| P304 | page(s) | 673-683 | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | Movement Disorders | Q1486418 |
| P1476 | title | The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation | |
| P478 | volume | 29 |
| Q55161995 | A Data-Driven Method for Generating Robust Symptom Onset Indicators in Huntington's Disease Registry Data. |
| Q92956179 | A probabilistic disease progression modeling approach and its application to integrated Huntington's disease observational data |
| Q41031227 | A stop-signal task for sheep: introduction and validation of a direct measure for the stop-signal reaction time. |
| Q38599326 | A systematic linguistic profile of spontaneous narrative speech in pre-symptomatic and early stage Huntington's disease |
| Q35787704 | Abnormal Electrophysiological Motor Responses in Huntington's Disease: Evidence of Premanifest Compensation |
| Q41518825 | Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington's disease. |
| Q89605499 | Accuracy of automated amygdala MRI segmentation approaches in Huntington's disease in the IMAGE-HD cohort |
| Q64067597 | Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys |
| Q89733981 | Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease |
| Q37382878 | Assistive Technology for Cognition and Health-related Quality of Life in Huntington's Disease. |
| Q30862037 | Attempted and successful compensation in preclinical and early manifest neurodegeneration - a review of task FMRI studies |
| Q57489816 | Cognitive Performance After a One-Year Multidisciplinary Intensive Rehabilitation Program for Huntington's Disease: An Observational Study |
| Q38928777 | Cognitive dysfunction in Huntington's disease: mechanisms and therapeutic strategies beyond BDNF. |
| Q38430852 | Cognitive interventions to enhance neural compensation in Huntington's disease |
| Q28393234 | Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study |
| Q37019338 | Compensatory activation in fronto-parietal cortices among HIV-infected persons during a monetary decision-making task |
| Q45294951 | Compromised Dopaminergic Encoding of Reward Accompanying Suppressed Willingness to Overcome High Effort Costs Is a Prominent Prodromal Characteristic of the Q175 Mouse Model of Huntington's Disease |
| Q104617061 | Dissociable Motivational Deficits in Pre-manifest Huntington's Disease |
| Q48112823 | Early Detection of Apathetic Phenotypes in Huntington's Disease Knock-in Mice Using Open Source Tools. |
| Q45721188 | Families Affected by Huntington's Disease Report Difficulties in Communication, Emotional Involvement, and Problem Solving. |
| Q64958688 | G-Computation and Hierarchical Models for Estimating Multiple Causal Effects From Observational Disease Registries With Irregular Visits. |
| Q38884150 | Health Care Delivery Practices in Huntington's Disease Specialty Clinics: An International Survey. |
| Q56083219 | Huntington disease |
| Q36090810 | Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway |
| Q92106147 | International Guidelines for the Treatment of Huntington's Disease |
| Q42110375 | Introduction: the importance of cognition in movement disorders |
| Q36379175 | Measuring compensation in neurodegeneration using MRI. |
| Q100462515 | Montreal Cognitive Assessment for evaluating cognitive impairment in Huntington's disease: a systematic review |
| Q45302525 | Myelin breakdown in human Huntington's disease: Multi-modal evidence from diffusion MRI and quantitative magnetization transfer. |
| Q40058208 | Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests |
| Q37739897 | Operationalizing compensation over time in neurodegenerative disease |
| Q38680458 | PIN1 Modulates Huntingtin Levels and Aggregate Accumulation: An In vitro Model |
| Q43182909 | Preserving cortico-striatal function: deep brain stimulation in Huntington's disease |
| Q37284640 | Problem solving, impulse control and planning in patients with early- and late-stage Huntington's disease |
| Q55010368 | Reduced amygdala volumes are related to motor and cognitive signs in Huntington's disease: The IMAGE-HD study. |
| Q36206024 | Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington's disease |
| Q55159264 | Sexual behavior and testis morphology in the BACHD rat model. |
| Q37514484 | Striatal morphology correlates with frontostriatal electrophysiological motor processing in Huntington's disease: an IMAGE-HD study. |
| Q92812803 | The Expanding Therapeutic Potential of Neuronal KCC2 |
| Q45304583 | The Neuropsychology of Huntington's Disease |
| Q42327973 | Theory of Mind Is Impaired in Mild to Moderate Huntington's Disease Independently from Global Cognitive Functioning. |
Search more.